Prelude Capital Management, LLC Infinity Pharmaceuticals, Inc. Transaction History

Prelude Capital Management, LLC

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2018 Feb 14, 2019	SELL	$1.01 - $2.78 $158,819 - $437,146	-157,247 Closed	0 $0
Q3 2018 Nov 14, 2018	BUY	$1.72 - $2.71 $123,556 - $194,672	71,835 Added 84.1%	157,247 $426,000
Q2 2018 Aug 14, 2018	BUY	$1.72 - $2.26 $146,908 - $193,031	85,412 New	85,412 $163,000

1.26M

Ticker INFI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 89,277,904
Description
Infinity Pharmaceuticals, Inc., a biopharmaceutical company, focuses on developing novel medicines for people with cancer. Its product candidate is IPI-549, an orally administered clinical-stage immuno-oncology product candidate that inhibits the enzyme phosphoinositide-3-kinase-gamma, which is in Phase 2 clinical trials for the treatment of met...

Get notified when there are updates to the investment portfolio of Prelude Capital Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Prelude Capital Management, LLC with notifications on news.